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Structural Features in the KshA Terminal Oxygenase Protein That
Determine Substrate Preference of 3-Ketosteroid
9a-Hydroxylase Enzymes
Mirjan Petrusma, Lubbert Dijkhuizen, and Robert van der Geize
Department of Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), University of Groningen, Groningen, The Netherlands
Rieske nonheme monooxygenase 3-ketosteroid 9a-hydroxylase (KSH) enzymes play a central role in bacterial steroid catabo-
lism. KSH is a two-component iron-sulfur-containing enzyme, with KshA representing the terminal oxygenase component and
KshB the reductase component. We previously reported that the KshA1 and KshA5 homologues of Rhodococcus rhodochrous
DSM43269 have clearly different substrate preferences. KshA protein sequence alignments and three-dimensional crystal struc-
ture information for KshAH37Rv of Mycobacterium tuberculosis H37Rv served to identify a variable region of 58 amino acids or-
ganized in a b sheet that is part of the so-called helix-grip fold of the predicted KshA substrate binding pocket. Exchange of the b
sheets between KshA1 and KshA5 resulted in active chimeric enzymes with substrate preferences clearly resembling those of the
donor enzymes. Exchange of smaller parts of the KshA1 and KshA5 b-sheet regions revealed that a highly variable loop region
located at the entrance of the active site strongly contributes to KSH substrate preference. This loop region may be subject to
conformational changes, thereby affecting binding of different substrates in the active site. This study provides novel insights
into KshA structure-function relationships and shows that KSH monooxygenase enzymes are amenable to protein engineering
for the development of biocatalysts with improved substrate specificities.
3Ketosteroid 9a-hydroxylase (KSH) is a Rieske-type nonhemeoxygenase (RO) that plays a central role in bacterial steroid
catabolism and is involved in opening of the steroid B ring (10).
Hydroxylated steroids are of industrial and medical interest since
many of them are bioactive compounds. 9a-Hydroxylated ste-
roids are of particular interest for the synthesis of corticosteroids
(14). KSH is a class IAmonooxygenase, a two-component enzyme
system comprised of the terminal oxygenase KshA, containing a
Rieske Fe2S2 cluster and a nonheme Fe
21 located at the active site,
and the reductaseKshB, containing a plant-type Fe2S2 cluster and the
flavin cofactor flavin adenine dinucleotide (2, 21, 25). Interestingly,
KshAandKshBbothhavebeen identified tobe essential factors in the
pathogenicity of Mycobacterium tuberculosis H37Rv (11).
Previously, we reported on the molecular and biochemical
characterization of five KshA homologues of Rhodococcus rhodo-
chrous DSM43269. Each of these five kshA genes displayed a
unique steroid induction pattern, coding for KshA enzymes with
an identical reaction selectivity (they all introduce a hydroxylmoi-
ety at the C-9 position of 3-ketosteroids), but interesting differ-
ences in their substrate preferences were observed (21, 22). Em-
powered with multiple kshA genes, R. rhodochrous DSM43269
may deal in an effective manner with the various sterol/steroid
substrates present in its natural habitat (soil), with C9a-
hydroxylation occurring at different levels during microbial ste-
roid degradation (22). The KshA5 homologue of DSM43269
(GenBank accession number ADY18328) has a broad substrate
rangewith no apparent preference for any of the tested steroids. In
contrast, the KshA1 homologue (GenBank accession number
ADY18310) has a narrow substrate range with a high preference
for 23,24-bisnorcholesta-4-ene-22-oic acid (4-BNC) and 23,24-
bisnorcholesta-1,4-diene-22-oic acid (1,4-BNC) and preference
to a lesser extent for 1,4-androstadiene-3,17-dione (ADD) and
4-pregnene-3,20-dione (progesterone) (22) (Tables 1 and 2). In
view of the relatively high protein sequence similarity of the
KshA1 and KshA5 homologues (61% amino acid identity), their
marked differences in substrate preferences may be based on sub-
tle but clearly different structural features. This prompted us to
study the structure-function relationships of these KshA enzymes.
Several three-dimensional (3D) structures of ROs are currently
available (3, 4, 6, 7, 8, 9, 13, 15, 17, 19, 20), including a single 3D
structure of KshA, namely, that of M. tuberculosis H37Rv (Rv3526;
KshAH37Rv) (2). Although the protein sequences of ROs vary consid-
erably, their tertiary structures are very similar overall. Characteristic
for ROs, including KshAH37Rv, is the formation of trimers. These
trimers either occur as a3 subunits (2, 4, 17, 19) or may additionally
include a smaller b subunit of the oxygenase component, resulting in
an (ab)3 enzyme complex (3, 6, 7, 8, 9, 13, 15, 20). The active site of
KshAH37Rv was shown to be composed of a b sheet, including a loop
region located at the entrance of the active site, flanked by two a
helices. The a helices that flank the b sheet contain residues that
coordinate the Fe21 atom at the core of the active site (2). This so-
calledhelix-grip foldof the active site is a commonfeatureofROsand
partof theStAR(steroidogenicacute regulatoryprotein)-related lipid
transfer (START) domain superfamily (12). Several amino acid resi-
dues predicted to be involved in steroid substrate binding were iden-
tified in a docking experiment with KshAH37Rv (2). All these residues
were located within the helix-grip fold, either in the aforementioned
b-sheet or in the flanking a helices.
To gain insight into the structural features responsible for the
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observed differences in the substrate preference of the homolo-
gous KshA enzymes of R. rhodochrous DSM43269, chimeric en-
zymes of KshA1 (KshA1A5) and KshA5 (KshA5A1) were con-
structed (Table 3; Fig. 1), and their KSH activities with a range of
steroid substrates were analyzed. The results show that a highly
variable loop region, located within the b sheet at the entrance of
the active site of KshA, strongly contributes to the substrate pref-
erence of these KSH enzymes.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Escherichia coli cloning strain
DH5a (Stratagene) and expression strain E. coli C41(DE3) (18) were
grown in Luria-Bertani (LB) medium at 37°C and 220 rpm unless stated
otherwise. Ampicillin was added to a final concentration of 100 mg ml21
when appropriate.
Steroids. 4-Androstene-3,17-dione (AD), 1,4-androstadiene-3,17-dione
(ADD), 19-nor-4-androstene-3,17-dione (nordion), 3a-hydroxy-5a-
pregnane-20-one, 5a-androstane-17b-ol-3-one (stanolon), 3b-hydroxy-
5a-androstane-17-one, and 9a-hydroxy-4-androstene-3,17-dione were
obtained from HSD (Oss, The Netherlands). 17b-Hydroxy-4-
androstene-3-one (testosterone), 11b-hydrocortisone, 3a-, 7a-, and
12a-trihydroxy-5b-cholan-24-ioc acid (cholic acid), and 5-cholestene-
3b-ol (cholesterol) were obtained from Sigma-Aldrich. 4-Pregnene-3,20-
dione (progesterone) was obtained from ICN Biomedicals Inc. 1-(5a)-
TABLE 1 Relative initial activities of wild-type and chimeric KshA1 with a range of steroid substrates
Steroid substrated
Relative initial KSH activitye
A1c A1A5b A1A5loop A1A5b201-210 A1D242W A1A5TG
4-Androstene-3,17-dione (AD) 100 100 100 100 100 100
1,4-Androstadiene-3,17-dione (ADD) 244 6 24 132 6 9a 171 6 10a 149 6 3a 307 6 28 274 6 22
4-Androstene-17b-ol-3-one (testosterone) 158 6 14 144 6 6 191 6 20 117 6 8a 205 6 26 193 6 17a
4-Pregnene-3,20-dione (progesterone) 372 6 59 213 6 22a 294 6 30 231 6 9a 499 6 91 468 6 34a
19-Nor-4-androstene-3,17-dione (nordion) 24 6 6 19 6 5 24 6 5 18 6 5 23 6 9 23 6 5
1-(5a)-Androstene-3,17-dione 23 6 4 22 6 3 25 6 5 13 6 1 19 6 4 14 6 5
5a-Androstane-3,17-dione 12 6 10 — 10 6 1 5 6 1 11 6 2 12 6 5
5b-Androstane-3,17-dione 19 6 4 8 6 5 6 6 1a 5 6 2a 13 8 6 2a
5-Cholestene-3b-ol (cholesterol)b — — — — — —
5a-Androstane-17b-ol-3-one (stanolon) — 7 6 3a 5a 4 6 1a 17 6 2a 11 6 4a
3a-Hydroxy-5a-pregnane-20-oneb — — — — — —
11b-Hydrocortisone — 7 6 5a 7 6 1a 15 6 4a 13 6 3a 10 6 3a
3b-Hydroxy-5a-androstane-17-one — — — — — —
23,24-Bisnorcholesta-4-ene-22-oic acid (4-BNC) 548 6 63 177 6 36a 241 6 12a 229 6 24a 704 6 141 953 6 137a
9a-Hydroxy-4-androstene-3,17-dione (9OHAD) — — — — — —
a P , 0.02 (analysis of variance).
b The steroid concentration is 25 mM due to low solubility.
c Data taken from Petrusma et al. (22).
d For chemical structures of steroids used in this study, see Fig. S1 in the supplemental material.
e Relative KSH activities (with standard deviations) compared to activity with AD, which is set at 100% (Table 4). Steroid substrates were tested at a concentration of 200 mM. —,
no initial KSH activity detectable.
TABLE 2 Relative activities of wild-type and chimeric KshA5 with a range of steroid substrates
Steroid substrated
Relative KSH activitye
A5c A5A1b A5A1loop A5A1b207-216 A5W248D
4-Androstene-3,17-dione (AD) 100 100 100 100 100
1,4-Androstadiene-3,17-dione (ADD) 51 6 4 189 6 35a 114 6 19a 53 6 4 66 6 8a
4-Androstene-17b-ol-3-one (testosterone) 113 6 20 155 6 19a 125 6 13 95 6 7 109 6 7
4-Pregnene-3,20-dione (progesterone) 65 6 1 179 6 37a 106 6 5a 95 6 21 74 6 9
19-Nor-4-androstene-3,17-dione (nordion) 111 6 18 28 6 5a 27 6 4a 118 6 7 102 6 10
1-(5a)-Androstene-3,17-dione 99 6 9 28 6 6a 33 6 3a 94 6 20 94 6 12
5a-Androstane-3,17-dione 73 6 6 13 6 1a 14 6 7a 69 6 9 58 6 14
5b-Androstane-3,17-dione 99 6 12 20 6 10a 25 6 5a 50 6 16a 55 6 3a
5-Cholestene-3b-ol (cholesterol)b — — — — —
5a-Androstane-17b-ol-3-one (stanolon) 100 6 10 — 16 6 3a 95 6 8 57 6 19a
3a-Hydroxy-5a-pregnane-20-oneb — — — — —
11b-Hydrocortisone 93 6 9 22 6 5a 24 6 11a 91 6 10 94 6 7
3b-Hydroxy-5a-androstane-17-one — — — — —
23,24-Bisnorcholesta-4-ene-22-oic acid (4-BNC) 88 6 11 216 6 44a 120 6 29 89 6 21 50 6 37
9a-Hydroxy-4-androstene-3,17-dione (9OHAD) — — — — —
a P , 0.02 (analysis of variance).
b Steroid concentration is 25 mM due to low solubility.
c Data taken from Petrusma et al. (22).
d For chemical structures of steroids used in this study, see Fig. S1 in the supplemental material.
e Relative KSH activities (with standard deviations) compared to activity with AD, which is set at 100% (Table 4). Steroid substrates were tested at a concentration of 200 mM. —,
no initial KSH activity detectable.
Petrusma et al.




















































Androstene-3,17-dione (1-5a-AD), 5a-androstane-3,17-dione (5a-AD),
5b-androstane-3,17-dione (5b-AD), and 23,24-bisnorcholesta-4-ene-
22-oic acid (4-BNC) were obtained from Steraloids. For chemical struc-
tures of the steroids used in this study, see Fig. S1 in the supplemental
material.
Construction of chimers of kshA1 and kshA5. Parts of the kshA1 (nu-
cleotides 591 to 767; encoding peptides E198 to V255) and kshA5 (nucle-
otides 609 to 785; encoding peptides E204 to I261) genes were exchanged
as BstBI/BclI DNA fragments, resulting in chimeric genes kshA1A5b and
kshA5A1b. The QuikChange site-directed mutagenesis protocol (Strat-
TABLE 3 Chimeric KshA enzymes used in this study
Chimeric KshA Template Description Mutation(s)
KSH
activitya
KshA1A5b KshA1 KshA1 with b sheet of KshA5 kshA1 E198 to V255 exchanged for kshA5 E204 to I261 1
KshA1A5a KshA1 KshA1 with a helix of KshA5 kshA1 I257 to I306 exchanged for kshA5 I263 to V312 2
KshA5A1b KshA5 KshA5 with b sheet of KshA1 kshA5 E204 to I261 exchanged for kshA1 E198 to V255 1
KshA5A1a KshA5 KshA5 with a helix of KshA1 kshA5 I263 to V312 exchanged for kshA1 I257 to I306 1/2




KshA1A5TG KshA1 KshA1 with 2 aa
c mutations at the
start of the loop
Q209T, A210G 1




KshA1A5b201-210 KshA1 KshA1 with mutations in b sheet V201T, S203T, F205Y, R207H, G208S, Q209T, A210G 1
KshA5A1b207-216 KshA5 KshA5 with mutations in b sheet T207V, T209S, Y211F, H213R, S214G, T215Q, G216A 1
KshA1A5b230-238
b KshA1 KshA1 with mutations in b sheet D230E, S232T, F238Y 2
KshA5A1b236-244 KshA5 KshA5 with mutations in b sheet E236D, T238S, Y244F 2
KshA1D242W KshA1 KshA1 with 1 aa mutation in b sheet D242W 1
KshA5W248D KshA5 KshA5 with 1 aa mutation in b sheet W248D 1
a Initial KSH activity with AD; 2, no initial KSH activity detectable; 1, KSH activity detectable (Table 4).
b Several cloning attempts were unsuccessful.
c aa, amino acids.
FIG 1 3D model structure of KshA1DSM43269 depicted as a cartoon. Green, a-helix domain; red, b-sheet domain exchanged between KshA1 and KshA5; purple
spheres, iron atoms; light blue, sulfur atoms. The first a helix (located above the nonheme iron indicated in blue), the b sheet (in red), and the second a helix (in
green) form the helix-grip fold. The loop region swapped betweenKshA1DSM43269 (a) andKshA5DSM43269 (b) is enlarged, and the amino acids are shown in sticks.
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agene) was used to introduce BclI sites in kshA1 and kshA5 by making the
silent point mutations C768G in kshA1 and C786G in kshA5. The BstBI
restriction site in kshA5 was introduced by a G612A silent mutation. For
the exchange of the second a helix, BclI/BglII DNA fragments were ex-
changed between kshA1 (nucleotides 768 to 920; encoding peptides I257
to I306) and kshA5 (nucleotides 786 to 938 of kshA5; encoding peptides
I263 to V312), resulting in chimeric genes kshA1A5a and kshA5A1a (Table
3). The PCR mixture contained 4 mM MgSO4, 2% dimethyl sulfoxide,
and 2.5 units (50 ml21) Pfu DNApolymerase (Fermentas) using pKSH814
and pA5rho5 (22) (see Table S1 in the supplemental material) as DNA
templates.
The chimeric genes kshA1A5loop, kshA1A5TG, and kshA5A1loop (Table 3)
were made via ligase-independent cloning (LIC) (23) using pKsh814 or
pA5rho5 (see Table S1 in the supplementalmaterial) as theDNA template
for PCR amplification.
The chimeric genes kshA1A5b201-210 and kshA1A5b230-238 (pKSH814 as
template) and kshA5A1b207-216 and kshA5A1b236-244 (pA5rho5 as template)
were constructed by PCR techniques (Table 3). The forward primers (see
Table S2 in the supplemental material) contain a stretch of DNA at the 5=
end (phosphorylated) corresponding to the bstretch donor gene. The PCR
mixtures consisted of Tris HCl (10 mM, pH 8.0), 13 polymerase buffer
with 1.5 mM MgCl2, MgCl2 (2.5 mM), deoxyribonucleotide triphos-
phates (0.2 mM), dimethyl sulfoxide (2%), primers (10 ng ml21), High
Fidelity DNA polymerase (0.5 units [25 ml21]; Fermentas), and 1 pg DNA
template under the following conditions: 5 min at 95°C and 30 cycles of 1
min at 95°C, 45 s at 68°C, and 4 min at 72°C, followed by 5 min at 72°C.
Site-directedmutagenesis (QuikChange protocol; see above) was used
to generate kshA1D242W and kshA5W248D (Table 3). Primers used in the
construction of the chimeric genes are shown in Table S2 in the supple-
mental material.
For uniformity, throughout the paper all mutant kshA genes are re-
ferred to as chimers.
Cloning, heterologous expression of KSH enzymes in E. coli, pro-
tein purification, and standard KSH enzyme activity assay. The chime-
ric kshA genes were cloned into expression vector pET15b (Novagen) and
then subcloned into pET15b containing kshBDSM43269, as described pre-
viously (21), to obtain constructs for coexpression of a kshA chimer with
kshB. Details of plasmid vectors used are given in Table S1 in the supple-
mental material. Coexpression of the chimeric KshA enzymes with KshB,
His tag purification of the enzymes yielding purified KSH enzymes, and
KSH activity assays were performed as described previously (21, 22). The
assay mixture (total volume, 500 ml) consisted of 50 mM Tris-HCl buffer
(pH 7.0), NADH (105 mM), 25 to 40 mg of KSH enzyme, and 200 mM
steroid substrate. NADH consumption over time was recorded with the
Soft-max PRO4 (Life Science edition) program. Activities were calculated
in nmol min21 mg21 of KSH enzyme. Km values (with standard devia-
tions) for the 4-BNC substrate were estimated by determining KSH activ-
ity over a range of substrate concentrations (1 to 200 mM). Sigmaplot
(version 10.0) was used to process the data using the Michaelis-Menten
formula y 5 (a 3 x)/(b 1 x) (21). Total uncoupling of the oxygenase
enzyme reaction, whichwould result inNADHoxidation but not product
formation, was checked by high-pressure liquid chromatography–UV or
gas chromatography (GC) analysis to confirm product formation (22).
KshA activity, as used in this paper, always refers to the activity of the
KSH enzyme (made up of the KshA wild-type or chimeric protein and the
KshB protein).
3D modeling of KshA1 and KshA5 of R. rhodochrous DSM43269.
The 3D crystal structure of KshAH37Rv (2) served as template (Protein
Data Bank [PDB] accession number 2ZYL) to model the tertiary struc-
tures of KshA1 and KshA5 of R. rhodochrous DSM43269. 3D models of
both KshA1DSM43269 and KshA5DSM43269 were generated on the SCWRL
server (http://www1.jcsg.org/scripts/prod/scwrl/serve.cgi). Alignments
were made using ClustalW (http://www.ebi.ac.uk/Tools/msa/clustalw2)
and edited manually using Vim (version 7.3.46). PyMOL (The PyMOL
Molecular Graphics System, version 1.1; Schrödinger, LLC) was used to
produce images.
RESULTS
Construction of chimeric enzymes of KshA1 and KshA5 of R.
rhodochrous DSM43269 by exchanging parts of the helix-fold
grip. Our previous work has shown that KshA1 and KshA5 of R.
rhodochrous DSM43269 are homologues with highly diverse sub-
strate preferences (22). KshA1 showed relatively high substrate
preferences for 4-BNC, ADD, and progesterone (Table 1),
whereas KshA5 displayed a broad substrate range (Table 2). We
exploited these differences in order to identify KshA regions in-
volved in substrate preference by constructing and characterizing
chimeric enzymes of KshA1 and KshA5. To identify regions of
interest within the putative substrate binding pocket as targets for
exchange between KshA1 and KshA5, we first aligned protein se-
quences of the 5 KshA homologues of DSM43269 with all the
known, e.g., KshAH37Rv (2), and putative KshA protein sequences
from databases (a total of 71 KshA amino acid sequences). In
addition, we constructed 3D structural models of KshA1 and
KshA5 using the 3D crystal structure of KshAH37Rv (2) (Fig. 1).
The KshA1 and KshA5 proteins share 60% amino acid identity
with KshAH37Rv. The protein sequence alignment (data not
shown) and the 3D models of KshA1 and KshA5 revealed that the
second a helix of the helix-grip fold (Fig. 1) contains many amino
acid residues that vary between KshA1 and KshA5. To investigate
whether these variations determine the differences in substrate
preference of the KshA homologues, the second a-helix region
was exchanged between KshA1 (I257 to I306) and KshA5 (I263 to
V312), resulting in the chimeric enzymesKshA1A5a andKshA5A1a
(Fig. 1; Table 3).
Several putative substrate-interacting residues of KshAH37Rv
are located within the b sheet of the helix-grip fold (2). Indeed,
this region contains highly conserved amino acid residues, but the
alignment also revealed several residues that differ betweenKshA1
and KshA5 (Fig. 2). To investigate whether this b sheet contrib-
utes to the differences in substrate preference of KshA1 and
KshA5, the b sheets (58 residues) of KshA1 (E198 to V255) and
KshA5 (E204 to I261) were exchanged and chimeric enzymes
KshA1A5b and KshA5A1b were constructed (Fig. 2; Table 3).
Chimeric KshA enzymes with exchanged helix-grip fold b
sheets retain KSH activity. In order to determine whether the
constructed KshA chimers retained KSH activity, the chimeric
KshA enzymes were coexpressed with KshBDSM43269 in E. coli
C41(DE3), copurified by nickel-nitrilotriacetic acid chromatogra-
phy, and subsequently assayed for KSH activity using
4-androstene-3,17-dione (AD) as the steroid substrate (Table 3).
KshA1A5b and KshA5A1b both clearly possessed KSH activity, in-
dicating that functional chimeric KshA enzymes had been con-
structed (Tables 3 and 4). In contrast, the chimeric enzyme
KshA1A5a did not show any detectable activity, and KshA5A1a
showed very low activity only. The molar ratio of KshA5A1a/KshB
was determined to be 1:8 6 0.83, indicating low levels of expres-
sion of soluble KshA5A1a enzyme, providing a possible explana-
tion for the low activity observed with KshA5A1a.
Substrate preferences of KshA1A5b and KshA5A1b. Next, we
determined the effects of the exchanged b-sheet regions on the
substrate preferences of both KshA1A5b and KshA5A1b by measur-
ing their KSH activity with a range of steroid substrates (Tables 1
and 2). Their enzyme activity levels cannot be directly compared,
Petrusma et al.




















































however, because the KshA/KshB molar ratios in the various pu-
rified KSH samples differed (Table 4). KSH enzyme activities with
the different substrates are therefore presented as percentages of
the activity with AD (set at 100%) and can thus be compared
between the different chimers (Table 4).
The exchange of the 58-amino-acid-residue b-sheet region
(Fig. 2) had a substantial effect on the substrate preferences of
both KshA1 and KshA5. Compared to wild-type KshA1, the pref-
erence of KshA1A5b for ADD, progesterone, and 4-BNC was sig-
nificantly reduced relative to that for AD (Table 1). Interestingly,
KshA1A5b activity with 4-BNC was reduced more than 3-fold
compared to that of KshA1. Consistent with the effect on the sub-
strate preference of KshA1, the KshA5A1b chimer displayed a
higher preference for ADD, progesterone, and 4-BNC than wild-
type KshA5, with a 2.5-fold increase in the activity with 4-BNC
(Table 2). Also, the KSH activity of KshA5A1b on nordion, 1-5a-
AD, 5a-AD, 5b-AD, and hydrocortisone was about 4-fold
lower than that of KshA5 (Table 2), more closely resembling
the substrate preference displayed by KshA1 (Table 1). Inter-
estingly, KshA5A1b activity with stanolon, a relatively good
substrate for KshA5, had become completely abolished. These
results show that exchange of the b sheets of the helix-grip fold
between different KshA homologues clearly affected their sub-
strate preferences.
KshA1-KshA5 chimeric enzymes with exchanged fragments
within the b-sheet region. To further narrow down the residues
potentially involved in KshA substrate preference, smaller regions
within the b sheets of KshA1 and KshA5 were exchanged (Fig. 2).
Several conserved residues putatively interacting with substrates
are located within the b-sheet region (Fig. 2). Amino acid residues
that are in close proximity to these putative substrate-interacting
residues and which differ between KshA1 and KshA5 were tar-
geted for exchange between these KshA homologues.
Striking is the large loop of 19 amino acid residues (loop re-
gion) that interrupts the b sheet and which appears to be poorly
conserved in the KshA amino acid sequence (Fig. 1 and 2).
KshA1A5loop and KshA5A1loop (Fig. 2) were found to retain KSH
activity with AD (Table 4). KshA1A5b201-210 and KshA5A1b207-216
(Fig. 2) were also successfully expressed and displayed KSH activ-
ity with AD (Table 4). However, the construction of the plasmid
for expression of KshA1A5b230-238 failed repeatedly for unknown
reasons, and chimeric enzyme KshA5A1b236-244 did not show any
detectable KSH activity.
Residues D242 (KshA1) and W248 were exchanged because
these highly different amino acids are situated directly adjacent to
the putative substrate-interacting amino acids D241 (KshA1) and
D247 (KshA5) (2). The chimeric enzymes KshA1D242W and
KshA5W248D (Table 3; Fig. 2) were successfully expressed and dis-
played KSH activity (Table 4).
The variable loop within the b sheet plays a role in the sub-
strate preference of KshA enzymes. The chimeric enzyme
KshA1A5b201-210 (Fig. 2) displayed an approximately 2-fold de-
crease in activity with ADD, progesterone, and 4-BNC relative to
KshA1 (Table 1). However, KshA5A1b207-216, the chimeric coun-
terpart of KshA1A5b201-210, is comparable to KshA5 in terms of its
substrate preference (Table 2). Interestingly, exchange of the 19-
amino-acid-residue loop regions (Fig. 1 and 2) affected the sub-
strate preferences in KshA1 and KshA5 in a way similar to that
observed with the exchange of the b sheets between these en-
zymes. KSH activity of KshA1A5loop with ADD and 4-BNC had
become reduced about 1.5-fold and .2-fold, respectively, com-
pared to that of KshA1 (Table 1). Also, the KshA5A1loop chimer
FIG 2 Amino acid sequences of the b-sheet regions exchanged between KshA1 and KshA5 resulting in the chimeric enzymes KshA1A5b and KshA5A1b,
respectively. The boxed amino acid residues were exchanged between KshA1 and KshA5, resulting in the chimeric enzymes KshA1A5loop, KshA1A5TG (italic),
KshA5A1loop, KshA1A5b201-210, KshA5A1b207-216, KshA1A5b230-238, KshA5A1b236-244, KshA1D242W, and KshA5W248D. p, putative substrate-interacting residues (2).








KshA1 1:1 6 0.16 261 6 11
KshA5 1:0.59 6 0.04 151 6 30
KshA1A5b 1:3.16 6 0.16 336 6 27
KshA5A1b 1:1.43 6 0.03 82 6 11
KshA1A5loop 1:1.6 6 0.1 366 6 25
KshA1A5TG 1:1.27 6 0.07 196 6 24
KshA5A1loop 1:1 6 0.01 248 6 24
KshA1A5b201-210 1:1.51 6 0.11 415 6 40
KshA5A1b207-216 1:0.93 6 0.04 421 6 34
KshA1D242W 1:1.86 6 0.04 125 6 20
KshA5W248D 1:2.6 6 0.3 231 6 22
a Determined by densitometry.
b Error is standard error of the mean (SEM), n 5 3.
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substrate preference more closely resembled that of KshA1 (Ta-
bles 1 and 2). The KSH activity of KshA5A1loop with the preferred
substrates of KshA1 (ADD, progesterone) had increased approx-
imately 2-fold. On the other hand, the activity of KshA5A1loop with
nordion, 1-5a-AD, 5a-AD, 5b-AD, stanolon, and hydrocortisone
was about 4-fold reduced compared to that of KshA1 (Tables 1
and 2). Surprisingly, there was no significant change in KSH ac-
tivity of KshA5A1loop toward 4-BNC.Overall, these results indicate
that the highly variable 19-amino-acid-residue loop region is an
important determinant of the substrate preferences of KshA1 and
KshA5.
When constructing KshA1A5loop, we accidently obtained a
KshA1A5 chimer harboring point mutations Q209T and
A210G, located at the entrance of the loop region (KshA1A5TG;
Fig. 2). These two point mutations were shown to have intrigu-
ing effects on the substrate preference of KshA1. Moreover,
KshA1A5TG displayed elevated activity with 4-BNC (almost
2-fold higher than that of wild-type KshA1), progesterone, and
testosterone (Table 1).
Exchange of the amino acid residues D242 (KshA1) and W248
(KshA5), located directly adjacent to a putative substrate-
interacting residue, did not have a substantial effect on substrate
preference. The substrate range of KshA1D242W was not signifi-
cantly different from that of KshA1, except that this chimeric en-
zyme had gained low activity with stanolon and hydrocortisone,
in contrast to wild-type KshA1 (Table 1). Conversely,
KshA5W248D displayed a strongly reduced activity with stanolon
compared towild-type KshA5 (Table 2). KshA5W248D also showed
an approximately 2-fold reduced activity with 5b-AD. However,
the activity of KshA1D242W with this substrate is similar to that of
wild-type enzyme KshA1.
Kinetic analysis of the activity of chimeric KshA enzymes
with 4-BNC. Several chimeric KshA enzymes showed significant
differences inKSHactivitywith 4-BNCcompared to thewild-type
enzymes (Tables 1 and 2). To investigate whether these differences
were due to changes in 4-BNC substrate affinity, kinetic studies
were performed to determine the 4-BNC affinity constants of all
enzymes. KshA1 andKshA5 both have a Km value of ,10 mMwith
4-BNC. Similar results were obtained with most of the chimeric
KshA enzymes. KshA1A5b andKshA5A1loop have Km values of 14 6
6 mM and 12 6 6 mM, respectively. KshA1A5loop shows an elevated
Km value of 43 6 10 mM relative to the wild-type enzyme KshA1.
This is in agreement with the finding that the KSH activity of
KshA1A5loop with 4-BNC was significantly lower than that of wild-
type KshA1 (Table 1). The reduced activity of this chimer with
4-BNC may thus be due to a lowered substrate affinity.
DISCUSSION
Insights into structure-function relationships of KSH enzymes
will aid in the engineering of KSH enzymes with higher activities
and/or improved substrate specificities. KSH is an interesting bio-
catalyst for the biotechnological production of 9a-hydroxylated
steroids. Moreover, both KshA and KshB are essential for patho-
genesis of M. tuberculosis. Detailed insights into the identity of
active-site residues interacting with substrates will provide a firm
basis for structure-based design of KSH inhibitors.
Using the successful coexpression and copurification protocol
previously developed for KshA and KshB of R. rhodochrous
DSM43269 (21), we also succeeded in constructing andproducing
mutantKSHenzymeswith chimers of 2 of the 5KshAhomologues
(this study). The majority of these KSH enzymes with chimeric
KshA proteins displayed KSH activity (Tables 3 and 4), providing
a clear scope for engineering of KshA proteins to optimize desir-
able properties. Interestingly, several of the KSH enzymes with
chimeric KshA proteins showed increased activities with AD com-
pared to the native KshA1 or KshA5 proteins (Table 4). However,
the KshA/KshB ratios vary between the different KshA chimers
(Table 4). These different KshA/KshB ratios may at least partly
account for the differences in KSH activities measured (21).
Thus, the conclusion that KSH enzymes displaying higher ac-
tivities indeed are made up of KshA chimers that are more
active is not warranted at present. Nevertheless, KSH enzymes
with KshA5A1b207-216 and KshA5A1loop have similar KshA/KshB
ratios (1:1), but KshA5A1b207-216 has a nearly 2-fold higher activity
with AD. Thus, KshA5A1b207-216 clearly provides a more active
KSH enzyme than KshA5A1loop.
In order to investigate whether the helix-grip fold b sheet,
which forms the basis of the catalytic domain, and the a helix that
flanks the b sheet are determinants of the substrate preference in
KshA enzymes, these regions were targeted for mutagenesis (Fig.
1). Exchange of the a helix between KshA1 and KshA5 resulted in
poorly active or fully inactive chimeric enzymes. Since the a helix
contains an Fe21 binding amino acid (2), we speculate that ex-
change of the a helix changed the tertiary structure in such a way
that the coordination of the Fe21 atom was altered in these chim-
ers, rendering them (virtually) inactive. Interestingly, exchange of
the b sheets yielded active chimeric enzymes KshA1A5b and
KshA5A1b (Table 3), displaying significantly altered substrate
preferences resembling more the preferences displayed by the
b-sheet donor enzyme. The data indicate that this specific helix-
grip fold b sheet plays an important role in the substrate prefer-
ences of KshA enzymes.
To further pinpoint the identity of residues determining
KshA substrate preference, smaller regions within the helix-
grip fold b sheet were exchanged between KshA1 and KshA5
(Fig. 2; Table 3). Intriguingly, chimeric KSH enzymes KshA1A5loop
and KshA5A1loop (Fig. 2) had significantly altered substrate pref-
erences, similar to KshA1A5b and KshA5A1b (Tables 1 and 2). Sim-
ilar loop regions have been found at the entrance of the active site
of various ROs. Ferraro et al. (5) already speculated that such
loops are involved in the accommodation of substrates in the ac-
tive site. The loop regions are disordered and have high-
temperature factors, indicating that they are very flexible. Di-
cambamonooxygenase (PDB accession number 3GKE) shows the
highest structural similarity (3D) with KshA of M. tuberculosis
(www.rcsb.org). On the basis of an analysis of the crystal struc-
tures of dicamba monooxygenase, D’Ordine et al. (4) suggested
that entry of the substrate into the active site is enabled by move-
ment of a helix region and a loop region, resulting in a more open
or closed state of the active site. Characterization of the KshA
chimeric proteins in the present study thus provides the first ex-
perimental evidence that the loop present at the entrance of the
active site strongly affects the substrate preference of KSH en-
zymes.
Analysis of further chimers showed that amino acid differences
between the b sheets of KshA1 and KshA5, apart from the varia-
tions within the loop region (Fig. 2), do not have strong effects on
the substrate preference of KSH enzymes. Nevertheless, these chi-
meric enzymes also display some significant differences from the
wild-type enzymes (Tables 1 and 2). Intriguing is the high sub-
Petrusma et al.




















































strate preference of KshA1A5TG for 4-BNC and progesterone (Ta-
ble 1). KshA1 mutant enzymes KshA1A5loop and KshA1A5b201-210
possess the same mutations as KshA1A5TG, in addition to other
mutations (Fig. 2; Table 3).However, both chimeric enzymes have
a decreased preference for both 4-BNC and progesterone com-
pared to KshA1 (Table 1). Thus, the additional mutations in
KshA1A5loop and KshA1A5b201-210 abolish the increase of activity
observed for KshA1A5TG with 4-BNC. Mutations Q209T and
A210G in KshA1 apparently facilitate a spatial configuration pre-
ferred for the accommodation of 4-BNC and, to a lower extent, of
progesterone.
In summary, the data presented in this paper show that a loop
region at the entrance of the KshA active site, part of the b sheet of
the helix-grip fold, strongly affects KSH substrate preference. This
loop region may be subject to conformational changes, thereby
affecting binding of different substrates in the active site. This
study provides novel insights into KshA structure-function rela-
tionships and shows that KSH enzymes are amenable to protein
engineering for the development of improved substrate specifici-
ties.
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